Article info

Download PDFPDF
Letter
Expanding the phenotype of MOG antibody-associated disease (MOGAD): half a century of epilepsy and relapsing optic neuritis

Authors

  • Iris Kleerekooper Department of Neuroinflammation, University College London, London, UK Department of Neuro-ophthalmology, National Hospital for Neurology and Neurosurgery, London, London, UK Dept of Neuro-ophthalmology, UCLH NHNN, UCL ION, Queen Square, Moorfields Eye Hospital, City Road Campus, London, UK PubMed articlesGoogle scholar articles
  • Sachid Anand Trip Department of Neuroinflammation, University College London, London, UK Dept of Neuro-ophthalmology, UCLH NHNN, UCL ION, Queen Square, Moorfields Eye Hospital, City Road Campus, London, UK PubMed articlesGoogle scholar articles
  • Gordon T Plant Department of Neuro-ophthalmology, National Hospital for Neurology and Neurosurgery, London, London, UK Dept of Neuro-ophthalmology, UCLH NHNN, UCL ION, Queen Square, Moorfields Eye Hospital, City Road Campus, London, UK PubMed articlesGoogle scholar articles
  • Axel Petzold Department of Neuro-ophthalmology, National Hospital for Neurology and Neurosurgery, London, London, UK Dept of Neuro-ophthalmology, UCLH NHNN, UCL ION, Queen Square, Moorfields Eye Hospital, City Road Campus, London, UK Dept of Neuro-ophthalmology, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Axel Petzold, UCLH NHNN, UCL ION, Queen Square, Moorfields Eye Hospital City Road Campus, London WC1E 6BT, UK; a.petzold{at}ucl.ac.uk
View Full Text

Citation

Kleerekooper I, Trip SA, Plant GT, et al
Expanding the phenotype of MOG antibody-associated disease (MOGAD): half a century of epilepsy and relapsing optic neuritis

Publication history

  • Received June 19, 2020
  • Revised September 19, 2020
  • Accepted September 21, 2020
  • First published November 4, 2020.
Online issue publication 
February 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.